News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ExonHit Therapeutics Inc. Extends Strategic Collaboration with Allergan Inc. (AGN)


11/2/2011 7:39:45 AM

PARIS--(BUSINESS WIRE)--Regulatory News: ExonHit S.A. (Alternext: ALEHT) today announced the extension of its existing drug discovery collaboration with Allergan Sales, LLC (NYSE: AGN). The collaboration was initiated in December 2002, and extended several times. It now is further extended until December 2013. The collaboration will continue to focus on the identification, development and commercialization of drugs for the treatment of neurodegenerative diseases, pain and ophthalmology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES